Evidence map›Paper›PMID 38673653›Full record

ArticleJournal of clinical medicine2024

Linezolid-Associated Thrombocytopenia: Assessment of Risk Factors in Patients without Hemato-Oncologic Diseases.

Abrar K Thabit, Arwa A Alghamdi, Afnan K Alsaeed, Nesereen M Magbool, Yazed S Alsowaida, Ahmad J Mahrous, Alya Alruwaili, Ziyad K Albakistani, Basem O Albangali, Anas M Alghumuy and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Abrar K ThabitPharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah 22254-2265, Saudi Arabia.ORCID 0000-0002-0369-9094
Arwa A AlghamdiFaculty of Pharmacy, King Abdulaziz University, Jeddah 22254-2265, Saudi Arabia.
Afnan K AlsaeedFaculty of Pharmacy, King Abdulaziz University, Jeddah 22254-2265, Saudi Arabia.
Nesereen M MagboolFaculty of Pharmacy, King Abdulaziz University, Jeddah 22254-2265, Saudi Arabia.
Yazed S AlsowaidaDepartment of Clinical Pharmacy, College of Pharmacy, University of Ha'il, Hail 55473, Saudi Arabia.ORCID 0000-0002-0450-9846
Ahmad J MahrousClinical Pharmacy Department, College of Pharmacy, Umm Al Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0002-7140-741X
Alya AlruwailiDepartment of Pharmaceutical Care, King Fahad Medical City, Riyadh 12231, Saudi Arabia.ORCID 0009-0000-9705-0183
Ziyad K AlbakistaniCollege of Pharmacy, Umm Al Qura University, Makkah 21955, Saudi Arabia.
Basem O AlbangaliCollege of Pharmacy, Umm Al Qura University, Makkah 21955, Saudi Arabia.
Anas M AlghumuyCollege of Pharmacy, Umm Al Qura University, Makkah 21955, Saudi Arabia.
Sara A YoussefDepartment of Pharmaceutical Care, Saudi German Hospital, Hail 55481, Saudi Arabia.
Reem M AlodayliDepartment of Pharmaceutical Care, Saudi German Hospital, Hail 55481, Saudi Arabia.
Masaad Saeed AlmutairiDepartment of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia.ORCID 0000-0001-6531-4877
King Abdulaziz University · SAUmm al-Qura University · SAUniversity of Ha'il · SAKing Fahd Medical City · SAQassim University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bacteremiacreatininecreatinine clearancelinezolidrenal insufficiencyrisk factorthrombocytopenia

Identifiers

PMID38673653
PMCPMC11050941
OpenAlexW4394953952

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.